Neurocrine Biosciences Inc (NBIX) SEC Filings — 2025
11 SEC filings for Neurocrine Biosciences Inc (NBIX) in 2025.
Filings
- Neurocrine Biosciences Inc 8-K Filing — 8-K · Nov 24, 2025
- Neurocrine's Q3 Net Income Soars 61% on Strong Product Sales — 10-Q · Oct 28, 2025
- Neurocrine's Q2 Sales Surge, Collaboration Revenue Doubles — 10-Q · Jul 30, 2025
- Neurocrine Biosciences Files 8-K on Officer/Director Changes — 8-K · May 30, 2025
- Neurocrine Biosciences Announces Executive and Board Changes — 8-K · May 22, 2025
- Neurocrine Biosciences Q1 2025 Update — 10-Q · May 5, 2025
- Neurocrine Biosciences Executive Compensation Filing — DEF 14A · Apr 9, 2025
- Neurocrine Biosciences Adds New Director — 8-K · Apr 4, 2025
- Neurocrine Biosciences Files 2024 Annual Report — 10-K · Feb 10, 2025
- Neurocrine Biosciences Files 8-K on Financials — 8-K · Feb 6, 2025
- Neurocrine Biosciences Enters Material Definitive Agreement — 8-K · Jan 27, 2025